Five separate activist positions landed at the SEC within forty-eight hours, targeting companies spanning orthopedic devices, Mexican airport infrastructure, aluminum rolling, satellite imaging, and RF filtration. Combined market capitalization under pressure: $18 billion. Smith & Nephew ($8.2B market cap) drew the largest filing, with concerns centered on margin compression in its Advanced Wound Management division and board composition. Grupo Aeroportuario del Sureste ($5.1B) faces questions over capital allocation following its Cancún terminal expansion. Constellium ($2.9B), Satellogic ($890M), and Oorvo ($1.1B) round out the cohort.

The filings arrived as Starboard Value separately disclosed a position in Autodesk ($68B market cap), signaling broader activist appetite for companies with governance friction or operational drift. Starboard's Jeff Smith has already engaged Autodesk's board over delayed disclosure of an internal accounting investigation—a pattern that rhymes with Smith & Nephew's own audit committee timeline gaps. The simultaneity is notable. Activist campaigns typically cluster around earnings seasons or proxy deadlines. This week's batch landed mid-quarter, suggesting either coordinated thesis development among funds or a recognition that boards are more vulnerable between reporting windows.

Smith & Nephew's activist challenge centers on 420 basis points of gross margin erosion since fiscal 2021. The company's wound care segment—once a cash generator—now trails ConvaTec and Mölnlycke in both product velocity and payor contracting. Grupo Aeroportuario's issue is different: the firm spent $1.2 billion on Cancún infrastructure while passenger growth in its Mérida and Oaxaca hubs stalled at 3% annually, well below the 7% Mexico-wide average. Constellium's activist is pressing for aerospace exposure monetization; the aluminum roller supplies Airbus and Boeing but trades at 0.4x book despite a $600 million backlog. Satellogic and Oorvo both face operational questions—satellite tasking margins and RF filter inventory turns, respectively.

The simultaneous pressure creates second-order effects. Smith & Nephew and Constellium share investor bases—Fidelity, BlackRock, Vanguard all hold material stakes in both. Fund managers now face activists in two portfolio positions at once, raising the probability of one-for-one vote swaps or coordinated governance demands. Grupo Aeroportuario's concession agreements with the Mexican government run through 2048; activist pressure on capital returns could force early dividend hikes or share buybacks that strain maintenance budgets. Satellogic's issue is existential: the company trades at $0.89 per share against a $10 SPAC entry price. An activist demanding a sale process or asset liquidation would face little shareholder resistance.

Operators should watch for three near-term catalysts. First: proxy advisory firm ISS and Glass Lewis will issue voting recommendations on any director slate challenges by late March, roughly ninety days out. Second: Smith & Nephew's Q1 earnings (April 24) will clarify whether wound care margins stabilized or continued their slide. Third: Starboard's Autodesk engagement—if it escalates to a public letter or 13D amendment—will set the template for how other activists prosecute governance-delay arguments. The Supreme Court's recent ruling barring activist investors from suing funds under Section 47(b) does not affect these campaigns; none target fund structures.

Constellium's backlog expires in eighteen months. If the activist cannot force a sale or aerospace spin by then, the thesis weakens.